Showing results (11-20 of 538) with videos related to
Sort By:
Pageof 54
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.Cancers|November 12, 2013
Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trialsMassimo Di Maio, Gennaro Daniele, Maria Carmela Piccirillo, et al.Expert Opinion on Biological Therapy|August 3, 2011
Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancerMassimo Di MaioRecenti Progressi in Medicina|March 12, 2020
[Could a medication management app help people to optimize their oral cancer drugs intake?]Massimo Di MaioCancer Investigation|April 21, 2023
The Value of Patient-Reported Outcomes in Single-Arm Cancer TrialsMassimo Di MaioRecenti Progressi in Medicina|November 18, 2020
[Outcomes reported by the patient: a tool for respecting the patient's rights and for involvement in research.]Massimo Di MaioAnnals of the New York Academy of Sciences|January 31, 2007
Hormonal treatment of human hepatocellular carcinomaMassimo Di Maio, Ermelinda De Maio, Alessandro Morabito, et al.Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.Anti-Cancer Drugs|November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumorsMassimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.Pageof 54